Archive
All News
Every briefing, headline, and filing we've published, newest first.
DealsBriefing
AstraZeneca resumes its shelved £300M UK expansion after rebate relief and a U.S.-U.K. pharma pact, signaling …
PipelineFiercePharma ↗
The FDA has released briefing documents detailing its concerns for AstraZeneca’s cancer drugs camizestrant and…
DealsFierceBiotech ↗
AbbVie has agreed to help finance a KRAS inhibitor from Kestrel Therapeutics in a deal that could hit up to $1…
PolicyBriefing
A judge approved Purdue Pharma’s criminal sentence, clearing the way for the company’s dissolution after years…
MoneyDrug Channels ↗
Today’s guest post comes from Cindy Baksh, Chief Product Officer at ConnectiveRx. Cindy explains that many gro…
PeopleSTAT News ↗
Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on va…
PipelineEndpoints News ↗
Bristol Myers Squibb’s cancer drug Krazati has failed its confirmatory study in second-line colorectal cancer,…
PolicyEndpoints News ↗
A powerful spending committee in Congress wants the FDA to ban the use of clinical trial data from China in fu…
PolicyEndpoints News ↗
WASHINGTON — Supreme Court justices gave a few hints about how they intend to rule in a divisive case for the …
PolicySTAT News ↗
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's n…
MoneyEndpoints News ↗
Wall Street’s expectations for Bristol Myers Squibb’s upcoming slate of data readouts are reaching a fever pit…
PolicySTAT News ↗
ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the cover…
DealsPharmaVoice ↗
Settlements delaying the arrival of generic versions of tafamidis will protect billions in Pfizer revenue and …
PolicyKFF Health News ↗
This brief reviews current federal and state policies on Medicaid and insurance coverage of abortion services …
DealsPharmaceutical Technology ↗
Chiesi will assume ownership of Ekterly, an on-demand pill approved for hereditary angioedema.…
DealsFiercePharma ↗
As Ekterly nears the one-year anniversary of its approval, Chiesi Group is making moves to acquire the rare di…
DealsFierceBiotech ↗
Eli Lilly’s latest attempt to strengthen its genetic medicine offering has seen the pharma team up with Proflu…
MoneyBriefing
Avalyn Pharma priced its Nasdaq debut at the top of range, raising $300M to push inhaled versions of existing …
PolicyKFF Health News ↗
A new KFF survey of state Medicaid officials and focus groups in eight states captures the different choices s…
PolicySTAT News ↗
At Wednesday's argument, the justices did not appear to question whether skinny labeling is valid.…
DealsBioPharma Dive ↗
A Jefferies analyst argued the deal — Teva’s largest in a decade — “makes se…
DealsBriefing
Chiesi has announced a $1.9B acquisition of KalVista Pharmaceuticals, continuing 2026’s brisk deal pace among …
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.